UB
CLDX icon

UMB Bank’s Celldex Therapeutics CLDX Stock Holding History

UMB Bank’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$68 – 2092
2024
Q3 		$68 Hold
2
– – ﹤0.01% 2132
2024
Q2 		$74 Hold
2
– – ﹤0.01% 2127
2024
Q1 		$84 Hold
2
– – ﹤0.01% 2137
2023
Q4 		$79 Hold
2
– – ﹤0.01% 1596
2023
Q3 		$55 Hold
2
– – ﹤0.01% 1682
2023
Q2 		$68 Hold
2
– – ﹤0.01% 1671
2023
Q1 		$72 Hold
2
– – ﹤0.01% 1683
2022
Q4 		$0 Hold
2
– – ﹤0.01% 1730
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1784
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1911
2022
Q1 		$0 Hold
2
– – ﹤0.01% 1986
2021
Q4 		$0 Buy
+2
New +$87 ﹤0.01% 1975

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return